1. Home
  2. CRON vs ACHC Comparison

CRON vs ACHC Comparison

Compare CRON & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$2.55

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Acadia Healthcare Company Inc.

ACHC

Acadia Healthcare Company Inc.

HOLD

Current Price

$23.22

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRON
ACHC
Founded
N/A
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
CRON
ACHC
Price
$2.55
$23.22
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$21.64
AVG Volume (30 Days)
1.0M
3.3M
Earning Date
05-28-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,587,000.00
$3,312,769,000.00
Revenue This Year
$32.15
$5.23
Revenue Next Year
$10.45
$5.97
P/E Ratio
N/A
N/A
Revenue Growth
24.63
5.04
52 Week Low
$1.60
$11.43
52 Week High
$3.43
$31.04

Technical Indicators

Market Signals
Indicator
CRON
ACHC
Relative Strength Index (RSI) 45.95 61.01
Support Level $2.44 $20.88
Resistance Level $2.59 $25.07
Average True Range (ATR) 0.07 1.32
MACD -0.00 -0.28
Stochastic Oscillator 30.33 38.86

Price Performance

Historical Comparison
CRON
ACHC

About CRON Cronos Group Inc.

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Share on Social Networks: